

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to mercury ion (GO:0046689) | 9.80215355 |
| 2 | one-carbon compound transport (GO:0019755) | 8.00427086 |
| 3 | metanephric nephron tubule development (GO:0072234) | 7.83842161 |
| 4 | metanephric tubule development (GO:0072170) | 7.83842161 |
| 5 | collecting duct development (GO:0072044) | 7.39922417 |
| 6 | metanephric nephron epithelium development (GO:0072243) | 7.18173270 |
| 7 | actin filament depolymerization (GO:0030042) | 6.80235587 |
| 8 | metanephric epithelium development (GO:0072207) | 6.67964245 |
| 9 | response to water (GO:0009415) | 6.28948399 |
| 10 | lysine metabolic process (GO:0006553) | 5.78391482 |
| 11 | lysine catabolic process (GO:0006554) | 5.78391482 |
| 12 | nephron tubule development (GO:0072080) | 5.61213774 |
| 13 | drug transmembrane transport (GO:0006855) | 5.61059412 |
| 14 | cell volume homeostasis (GO:0006884) | 5.60913167 |
| 15 | urate metabolic process (GO:0046415) | 5.30457946 |
| 16 | sphingomyelin metabolic process (GO:0006684) | 5.26807904 |
| 17 | drug transport (GO:0015893) | 5.14925772 |
| 18 | cardiovascular system development (GO:0072358) | 4.94931028 |
| 19 | renal tubule development (GO:0061326) | 4.94652713 |
| 20 | organic cation transport (GO:0015695) | 4.73737194 |
| 21 | response to copper ion (GO:0046688) | 4.71740499 |
| 22 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.68097768 |
| 23 | hyperosmotic response (GO:0006972) | 4.55344160 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.54759441 |
| 25 | nephron epithelium development (GO:0072009) | 4.51442102 |
| 26 | renal system process (GO:0003014) | 4.24573500 |
| 27 | water transport (GO:0006833) | 4.18722390 |
| 28 | branched-chain amino acid metabolic process (GO:0009081) | 4.04436116 |
| 29 | branched-chain amino acid catabolic process (GO:0009083) | 3.97828118 |
| 30 | response to salt stress (GO:0009651) | 3.97286457 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 3.95767767 |
| 32 | fluid transport (GO:0042044) | 3.94891708 |
| 33 | phosphate ion transport (GO:0006817) | 3.86707662 |
| 34 | phospholipid scrambling (GO:0017121) | 3.70207503 |
| 35 | quaternary ammonium group transport (GO:0015697) | 3.63423465 |
| 36 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.57339872 |
| 37 | nephron tubule morphogenesis (GO:0072078) | 3.55782133 |
| 38 | nephron epithelium morphogenesis (GO:0072088) | 3.55782133 |
| 39 | hyperosmotic salinity response (GO:0042538) | 3.55723388 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.53677775 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.53677775 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.53677775 |
| 43 | phosphate ion homeostasis (GO:0055062) | 3.46688164 |
| 44 | trivalent inorganic anion homeostasis (GO:0072506) | 3.46688164 |
| 45 | toxin transport (GO:1901998) | 3.41849201 |
| 46 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.40623665 |
| 47 | valine metabolic process (GO:0006573) | 3.38695246 |
| 48 | cysteine metabolic process (GO:0006534) | 3.35004750 |
| 49 | vitamin D metabolic process (GO:0042359) | 3.34291497 |
| 50 | glutathione biosynthetic process (GO:0006750) | 3.33728833 |
| 51 | 2-oxoglutarate metabolic process (GO:0006103) | 3.32826602 |
| 52 | phosphate ion transmembrane transport (GO:0035435) | 3.31436675 |
| 53 | carnitine metabolic process (GO:0009437) | 3.30592992 |
| 54 | detection of bacterium (GO:0016045) | 3.29422883 |
| 55 | positive regulation of digestive system process (GO:0060456) | 3.25679858 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.25461544 |
| 57 | inositol metabolic process (GO:0006020) | 3.25043309 |
| 58 | interferon-gamma production (GO:0032609) | 3.24840394 |
| 59 | oligosaccharide catabolic process (GO:0009313) | 3.24029341 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.18983583 |
| 61 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.17826066 |
| 62 | transepithelial transport (GO:0070633) | 3.15656593 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 3.15627893 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 3.15127643 |
| 65 | nephron tubule formation (GO:0072079) | 3.14329768 |
| 66 | regulation of fever generation (GO:0031620) | 3.13484996 |
| 67 | sodium ion transport (GO:0006814) | 3.09408712 |
| 68 | glyoxylate metabolic process (GO:0046487) | 3.06325596 |
| 69 | exogenous drug catabolic process (GO:0042738) | 3.04751313 |
| 70 | aromatic amino acid family catabolic process (GO:0009074) | 3.03062343 |
| 71 | detection of other organism (GO:0098543) | 3.00308939 |
| 72 | renal tubule morphogenesis (GO:0061333) | 2.97261343 |
| 73 | drug catabolic process (GO:0042737) | 2.96863211 |
| 74 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.96345661 |
| 75 | positive regulation of heat generation (GO:0031652) | 2.95612031 |
| 76 | amino-acid betaine transport (GO:0015838) | 2.91510677 |
| 77 | carnitine transport (GO:0015879) | 2.91510677 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 2.90325843 |
| 79 | response to phenylpropanoid (GO:0080184) | 2.89283156 |
| 80 | inorganic anion transport (GO:0015698) | 2.89172170 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 2.86174956 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84743079 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 2.83744184 |
| 84 | tricarboxylic acid metabolic process (GO:0072350) | 2.81637695 |
| 85 | L-phenylalanine metabolic process (GO:0006558) | 2.80072260 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.80072260 |
| 87 | wound healing, spreading of epidermal cells (GO:0035313) | 2.79543757 |
| 88 | pattern specification involved in kidney development (GO:0061004) | 2.78630302 |
| 89 | glycoside metabolic process (GO:0016137) | 2.76040966 |
| 90 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.70642440 |
| 91 | biotin metabolic process (GO:0006768) | 2.69791551 |
| 92 | kynurenine metabolic process (GO:0070189) | 2.67866393 |
| 93 | sphingosine metabolic process (GO:0006670) | 2.64271468 |
| 94 | fatty acid oxidation (GO:0019395) | 2.64158701 |
| 95 | ketone body metabolic process (GO:1902224) | 2.64075473 |
| 96 | tricarboxylic acid cycle (GO:0006099) | 2.63464132 |
| 97 | lipid oxidation (GO:0034440) | 2.63056068 |
| 98 | polyol transport (GO:0015791) | 12.8734853 |
| 99 | excretion (GO:0007588) | 10.6246367 |
| 100 | renal absorption (GO:0070293) | 10.1166655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.58962675 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.32481854 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.07280836 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.78727915 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.59839974 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50568574 |
| 7 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.38764984 |
| 8 | RXR_22108803_ChIP-Seq_LS180_Human | 2.00537967 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.95597442 |
| 10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.91442103 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89464684 |
| 12 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87821265 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.86735284 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84901214 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.81790954 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.77828958 |
| 17 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.73414241 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69765230 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.67067961 |
| 20 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.66253747 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60754135 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59698511 |
| 23 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58053614 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.57347171 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.56899598 |
| 26 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.56284917 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.55627355 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.54305171 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50768652 |
| 30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50356900 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50277193 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.48968863 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48607873 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47710982 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46603445 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45922079 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43196185 |
| 38 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41648395 |
| 39 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41360583 |
| 40 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.40861089 |
| 41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40595140 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34147514 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33616997 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33485260 |
| 45 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.30997637 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.30997637 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29659335 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.29528088 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26734045 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22258683 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22139469 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22064173 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21462901 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21249369 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20437810 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19846376 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19689590 |
| 58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17525415 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17445476 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17089472 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16507559 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15920150 |
| 63 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14930175 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13452413 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13143409 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12755972 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12242891 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11617850 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11291424 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11213497 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08232463 |
| 72 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07927642 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07721730 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07315700 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06188058 |
| 76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05288364 |
| 77 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.04938960 |
| 78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03861758 |
| 79 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01978864 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01228825 |
| 81 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99835811 |
| 82 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99141244 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98160387 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97636441 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97098686 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97066395 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96128534 |
| 88 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95247269 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94935071 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94486230 |
| 91 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.94152113 |
| 92 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.93967428 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93286270 |
| 94 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93066641 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92531520 |
| 96 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92417798 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92049314 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92049314 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91664450 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90585961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 9.45029825 |
| 2 | MP0003195_calcinosis | 8.27593347 |
| 3 | MP0001756_abnormal_urination | 5.85702409 |
| 4 | MP0009643_abnormal_urine_homeostasis | 3.58996603 |
| 5 | MP0001765_abnormal_ion_homeostasis | 3.56876090 |
| 6 | MP0005332_abnormal_amino_acid | 3.35892223 |
| 7 | MP0002136_abnormal_kidney_physiology | 3.07865797 |
| 8 | MP0005360_urolithiasis | 2.98962208 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.81361312 |
| 10 | MP0004885_abnormal_endolymph | 2.77464275 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.70653667 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 2.67877991 |
| 13 | MP0003283_abnormal_digestive_organ | 2.64901400 |
| 14 | MP0000538_abnormal_urinary_bladder | 2.37762621 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.20167703 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.12324861 |
| 17 | MP0003646_muscle_fatigue | 1.89789546 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 1.67862000 |
| 19 | MP0003878_abnormal_ear_physiology | 1.67862000 |
| 20 | MP0002168_other_aberrant_phenotype | 1.61811645 |
| 21 | MP0000534_abnormal_ureter_morphology | 1.51110109 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.44423507 |
| 23 | MP0001270_distended_abdomen | 1.42111714 |
| 24 | MP0003252_abnormal_bile_duct | 1.38703531 |
| 25 | MP0003941_abnormal_skin_development | 1.35515606 |
| 26 | MP0008004_abnormal_stomach_pH | 1.29105433 |
| 27 | MP0002896_abnormal_bone_mineralization | 1.23203810 |
| 28 | MP0002933_joint_inflammation | 1.20811196 |
| 29 | MP0009278_abnormal_bone_marrow | 1.19064475 |
| 30 | MP0005085_abnormal_gallbladder_physiolo | 1.17852963 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.15822823 |
| 32 | MP0002135_abnormal_kidney_morphology | 1.14403250 |
| 33 | MP0002928_abnormal_bile_duct | 1.10335363 |
| 34 | MP0004147_increased_porphyrin_level | 1.09506441 |
| 35 | MP0001764_abnormal_homeostasis | 1.08965044 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.07753518 |
| 37 | MP0000230_abnormal_systemic_arterial | 1.07647413 |
| 38 | MP0005395_other_phenotype | 1.03929175 |
| 39 | MP0004742_abnormal_vestibular_system | 1.03798002 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.00683913 |
| 41 | MP0000163_abnormal_cartilage_morphology | 0.99174904 |
| 42 | MP0002282_abnormal_trachea_morphology | 0.96524749 |
| 43 | MP0002115_abnormal_skeleton_extremities | 0.95991026 |
| 44 | MP0000762_abnormal_tongue_morphology | 0.95869205 |
| 45 | MP0003959_abnormal_lean_body | 0.95211924 |
| 46 | MP0002796_impaired_skin_barrier | 0.94056504 |
| 47 | MP0001958_emphysema | 0.92431093 |
| 48 | MP0005535_abnormal_body_temperature | 0.92124248 |
| 49 | MP0009379_abnormal_foot_pigmentation | 0.89779531 |
| 50 | MP0001188_hyperpigmentation | 0.89507997 |
| 51 | MP0005451_abnormal_body_composition | 0.87517733 |
| 52 | MP0005503_abnormal_tendon_morphology | 0.87331950 |
| 53 | MP0005365_abnormal_bile_salt | 0.86834817 |
| 54 | MP0003795_abnormal_bone_structure | 0.83110682 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 0.77917123 |
| 56 | MP0001299_abnormal_eye_distance/ | 0.77873925 |
| 57 | MP0002736_abnormal_nociception_after | 0.76769396 |
| 58 | MP0010386_abnormal_urinary_bladder | 0.75955528 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 0.74688265 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70718411 |
| 61 | MP0004484_altered_response_of | 0.69618797 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 0.68923929 |
| 63 | MP0003186_abnormal_redox_activity | 0.68555358 |
| 64 | MP0009764_decreased_sensitivity_to | 0.67499300 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.66899428 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 0.66891732 |
| 67 | MP0003436_decreased_susceptibility_to | 0.66351087 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.66216332 |
| 69 | MP0002998_abnormal_bone_remodeling | 0.66111001 |
| 70 | MP0001177_atelectasis | 0.64692308 |
| 71 | MP0002113_abnormal_skeleton_development | 0.64052112 |
| 72 | MP0005501_abnormal_skin_physiology | 0.63475962 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.60874052 |
| 74 | MP0000372_irregular_coat_pigmentation | 0.60862872 |
| 75 | MP0002098_abnormal_vibrissa_morphology | 0.59552669 |
| 76 | MP0001873_stomach_inflammation | 0.58682353 |
| 77 | MP0004272_abnormal_basement_membrane | 0.57171976 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 0.56582613 |
| 79 | MP0002735_abnormal_chemical_nociception | 0.55044956 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 0.53793184 |
| 81 | MP0000026_abnormal_inner_ear | 0.53039298 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.52934972 |
| 83 | MP0001542_abnormal_bone_strength | 0.52455137 |
| 84 | MP0003942_abnormal_urinary_system | 0.51265268 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.50817732 |
| 86 | MP0001191_abnormal_skin_condition | 0.48598677 |
| 87 | MP0005165_increased_susceptibility_to | 0.46424211 |
| 88 | MP0009642_abnormal_blood_homeostasis | 0.45377799 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.45231602 |
| 90 | MP0003724_increased_susceptibility_to | 0.44536032 |
| 91 | MP0001664_abnormal_digestion | 0.44521440 |
| 92 | MP0004134_abnormal_chest_morphology | 0.42283571 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.42214102 |
| 94 | MP0009250_abnormal_appendicular_skeleto | 0.41686754 |
| 95 | MP0006276_abnormal_autonomic_nervous | 0.40985022 |
| 96 | MP0004133_heterotaxia | 0.39709485 |
| 97 | MP0004381_abnormal_hair_follicle | 0.39255978 |
| 98 | MP0005390_skeleton_phenotype | 0.38296378 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.38018927 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.36735936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of chloride homeostasis (HP:0011422) | 9.15166322 |
| 2 | Polyuria (HP:0000103) | 8.62184640 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 8.44850062 |
| 4 | Increased circulating renin level (HP:0000848) | 8.42509069 |
| 5 | Hypomagnesemia (HP:0002917) | 8.10667788 |
| 6 | Abnormal urine output (HP:0012590) | 7.91263720 |
| 7 | Hyperaldosteronism (HP:0000859) | 7.58658469 |
| 8 | Renal salt wasting (HP:0000127) | 7.50733854 |
| 9 | Abnormality of renal excretion (HP:0011036) | 7.06041001 |
| 10 | Abnormality of magnesium homeostasis (HP:0004921) | 6.96948557 |
| 11 | Polydipsia (HP:0001959) | 6.54545025 |
| 12 | Abnormal drinking behavior (HP:0030082) | 6.54545025 |
| 13 | Tetany (HP:0001281) | 6.32154535 |
| 14 | Alkalosis (HP:0001948) | 5.94412512 |
| 15 | Abnormality of renin-angiotensin system (HP:0000847) | 5.28148335 |
| 16 | Hypokalemia (HP:0002900) | 4.96114712 |
| 17 | Abnormality of sodium homeostasis (HP:0010931) | 4.20255167 |
| 18 | Gout (HP:0001997) | 3.95381416 |
| 19 | Abnormality of potassium homeostasis (HP:0011042) | 3.93234822 |
| 20 | Adrenal overactivity (HP:0002717) | 3.67610786 |
| 21 | Hypercalciuria (HP:0002150) | 3.54782446 |
| 22 | Hyponatremia (HP:0002902) | 3.53512128 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29917345 |
| 24 | Epiphyseal dysplasia (HP:0002656) | 3.21590062 |
| 25 | Hyperuricemia (HP:0002149) | 2.87578656 |
| 26 | Increased purine levels (HP:0004368) | 2.87578656 |
| 27 | Dehydration (HP:0001944) | 2.50796280 |
| 28 | Abnormal tarsal ossification (HP:0008369) | 2.49971912 |
| 29 | Nephrocalcinosis (HP:0000121) | 2.48487791 |
| 30 | Chondrocalcinosis (HP:0000934) | 2.47224824 |
| 31 | Irregular epiphyses (HP:0010582) | 2.43263830 |
| 32 | Proximal tubulopathy (HP:0000114) | 2.40108416 |
| 33 | Abnormality of Sharpey fibers (HP:0100685) | 2.39874543 |
| 34 | Vitreoretinal degeneration (HP:0000655) | 2.33939011 |
| 35 | Delayed epiphyseal ossification (HP:0002663) | 2.29835489 |
| 36 | Decreased circulating renin level (HP:0003351) | 2.22526406 |
| 37 | Generalized muscle weakness (HP:0003324) | 2.14099307 |
| 38 | Large eyes (HP:0001090) | 2.09339347 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 2.07681776 |
| 40 | Neonatal short-limb short stature (HP:0008921) | 2.03822995 |
| 41 | Metabolic alkalosis (HP:0200114) | 11.5980130 |
| 42 | Hypokalemic alkalosis (HP:0001949) | 10.3836061 |
| 43 | Hyperglycinuria (HP:0003108) | 1.96845681 |
| 44 | Hypotension (HP:0002615) | 1.92406866 |
| 45 | Renal tubular acidosis (HP:0001947) | 1.91624716 |
| 46 | Flat capital femoral epiphysis (HP:0003370) | 1.88112532 |
| 47 | Hypoplastic ischia (HP:0003175) | 1.83297154 |
| 48 | Ketoacidosis (HP:0001993) | 1.83192736 |
| 49 | Neonatal onset (HP:0003623) | 1.82976980 |
| 50 | Cupped ribs (HP:0000887) | 1.79483245 |
| 51 | Abnormality of the renal cortex (HP:0011035) | 1.78961418 |
| 52 | Vomiting (HP:0002013) | 1.76361338 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.72911462 |
| 54 | Tubulointerstitial fibrosis (HP:0005576) | 1.72099776 |
| 55 | Metaphyseal cupping (HP:0003021) | 1.62601951 |
| 56 | Abnormal foot bone ossification (HP:0010675) | 1.61763396 |
| 57 | Metaphyseal irregularity (HP:0003025) | 1.60521366 |
| 58 | Generalized aminoaciduria (HP:0002909) | 1.60353153 |
| 59 | Short femoral neck (HP:0100864) | 1.60213748 |
| 60 | Abnormality of carpal bone ossification (HP:0006257) | 1.58940600 |
| 61 | Metaphyseal dysplasia (HP:0100255) | 1.58356775 |
| 62 | Abnormality of the ischium (HP:0003174) | 1.55691835 |
| 63 | Arthropathy (HP:0003040) | 1.53798953 |
| 64 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.53046734 |
| 65 | Flattened epiphyses (HP:0003071) | 1.52905613 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.52123167 |
| 67 | Abnormality of glycine metabolism (HP:0010895) | 1.52123167 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 1.51543714 |
| 69 | Glycosuria (HP:0003076) | 1.51543714 |
| 70 | Flat acetabular roof (HP:0003180) | 1.51206628 |
| 71 | Tubular atrophy (HP:0000092) | 1.47500202 |
| 72 | Impaired platelet aggregation (HP:0003540) | 1.46605624 |
| 73 | Abnormal platelet function (HP:0011869) | 1.46605624 |
| 74 | Protuberant abdomen (HP:0001538) | 1.46593902 |
| 75 | Vascular calcification (HP:0004934) | 1.45328389 |
| 76 | Genu varum (HP:0002970) | 1.41406959 |
| 77 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.38105926 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 1.35123187 |
| 79 | Abnormality of the vertebral endplates (HP:0005106) | 1.34332596 |
| 80 | Potter facies (HP:0002009) | 1.33920671 |
| 81 | Facial shape deformation (HP:0011334) | 1.33920671 |
| 82 | Abnormality of the renal medulla (HP:0100957) | 1.33762087 |
| 83 | Ketosis (HP:0001946) | 1.32650058 |
| 84 | Small epiphyses (HP:0010585) | 1.32264659 |
| 85 | Abnormality of femoral epiphyses (HP:0006499) | 1.31980755 |
| 86 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.31980755 |
| 87 | Premature birth (HP:0001622) | 1.27910070 |
| 88 | Cardiovascular calcification (HP:0011915) | 1.24211760 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 1.24169341 |
| 90 | Hydroxyprolinuria (HP:0003080) | 1.24169341 |
| 91 | Disproportionate short-trunk short stature (HP:0003521) | 1.23278481 |
| 92 | Enlarged kidneys (HP:0000105) | 1.23033468 |
| 93 | Abnormality of renal resorption (HP:0011038) | 1.23018985 |
| 94 | Hyperphosphaturia (HP:0003109) | 1.22517935 |
| 95 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.22218389 |
| 96 | Abnormal urine phosphate concentration (HP:0012599) | 1.22198275 |
| 97 | Renal tubular dysfunction (HP:0000124) | 1.20030993 |
| 98 | Glomerulosclerosis (HP:0000096) | 1.18509487 |
| 99 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.17535184 |
| 100 | Abnormality of the femoral head (HP:0003368) | 1.16736101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 7.20054752 |
| 2 | WNK4 | 4.87216778 |
| 3 | SGK2 | 2.57184671 |
| 4 | SGK223 | 2.34634200 |
| 5 | SGK494 | 2.34634200 |
| 6 | MST4 | 2.05472644 |
| 7 | WNK3 | 12.4512196 |
| 8 | SGK3 | 1.85776267 |
| 9 | BCKDK | 1.59917067 |
| 10 | STK39 | 1.43590661 |
| 11 | MST1R | 1.37864105 |
| 12 | STK38L | 1.36534860 |
| 13 | WNK1 | 1.23506204 |
| 14 | PDK3 | 1.16517605 |
| 15 | PDK4 | 1.16517605 |
| 16 | INSRR | 1.05555742 |
| 17 | PDK2 | 1.02037620 |
| 18 | ERBB3 | 0.97306638 |
| 19 | DDR2 | 0.81422349 |
| 20 | NME1 | 0.77016844 |
| 21 | GRK1 | 0.74775339 |
| 22 | MUSK | 0.74682217 |
| 23 | IRAK2 | 0.67405356 |
| 24 | MAP3K3 | 0.66630751 |
| 25 | STK38 | 0.61876034 |
| 26 | TGFBR2 | 0.57170431 |
| 27 | AKT3 | 0.56862423 |
| 28 | TRPM7 | 0.56447322 |
| 29 | SGK1 | 0.56034562 |
| 30 | TIE1 | 0.55566438 |
| 31 | NLK | 0.53363181 |
| 32 | PRKG2 | 0.50802478 |
| 33 | EPHA2 | 0.47182504 |
| 34 | PINK1 | 0.45504801 |
| 35 | PIK3CG | 0.43902431 |
| 36 | ADRBK2 | 0.43293741 |
| 37 | MAPKAPK5 | 0.43279430 |
| 38 | IRAK3 | 0.40462987 |
| 39 | MAP3K14 | 0.40432419 |
| 40 | FGFR4 | 0.40078254 |
| 41 | CASK | 0.37074482 |
| 42 | MAPK15 | 0.36880039 |
| 43 | TXK | 0.35867466 |
| 44 | PRKCD | 0.32751234 |
| 45 | PIM2 | 0.32606211 |
| 46 | IRAK1 | 0.32465969 |
| 47 | PRKAA1 | 0.30090775 |
| 48 | NUAK1 | 0.28364553 |
| 49 | NEK6 | 0.28089524 |
| 50 | CSNK1A1 | 0.28000904 |
| 51 | MAPK7 | 0.27472280 |
| 52 | LRRK2 | 0.27153129 |
| 53 | YES1 | 0.25443369 |
| 54 | TEC | 0.23991134 |
| 55 | MET | 0.23755741 |
| 56 | PRKCE | 0.23321497 |
| 57 | PAK3 | 0.22883953 |
| 58 | MAP2K2 | 0.21279171 |
| 59 | PRKACA | 0.21047514 |
| 60 | PRKCQ | 0.19832546 |
| 61 | GSK3A | 0.19739575 |
| 62 | ITK | 0.19150102 |
| 63 | MAP3K12 | 0.18943334 |
| 64 | MKNK1 | 0.17747004 |
| 65 | BCR | 0.17707498 |
| 66 | NME2 | 0.17548935 |
| 67 | NTRK2 | 0.16677081 |
| 68 | PRKACG | 0.15843052 |
| 69 | PRKCA | 0.15098050 |
| 70 | GRK6 | 0.15050776 |
| 71 | MAP3K7 | 0.14878322 |
| 72 | IGF1R | 0.14401036 |
| 73 | MAPK4 | 0.13819723 |
| 74 | EIF2AK2 | 0.13441100 |
| 75 | EPHA4 | 0.13391704 |
| 76 | MAP2K6 | 0.12893572 |
| 77 | EPHB2 | 0.12522620 |
| 78 | ADRBK1 | 0.11439910 |
| 79 | PAK4 | 0.10220993 |
| 80 | CHUK | 0.10067753 |
| 81 | FER | 0.08767531 |
| 82 | PRKCI | 0.08517615 |
| 83 | CAMK4 | 0.08068621 |
| 84 | BMPR2 | 0.08059756 |
| 85 | NEK1 | 0.07734639 |
| 86 | PIM1 | 0.07373534 |
| 87 | PRKCZ | 0.06877081 |
| 88 | PDGFRA | 0.06788088 |
| 89 | PRKCH | 0.06719668 |
| 90 | IKBKB | 0.05731200 |
| 91 | PRKCG | 0.05191500 |
| 92 | SRC | 0.04978569 |
| 93 | CAMK2A | 0.04896276 |
| 94 | CSK | 0.04415819 |
| 95 | AURKB | 0.03518480 |
| 96 | NTRK1 | 0.03159676 |
| 97 | MAPK3 | 0.02926192 |
| 98 | GRK7 | 0.02673725 |
| 99 | ROCK1 | 0.02433262 |
| 100 | MELK | 0.02334221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.70118448 |
| 2 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.65764384 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.25821901 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.04675327 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.98015559 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.94102346 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.88771395 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.60755988 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57682937 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.40371834 |
| 11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.34465677 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.31545487 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22804271 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22334986 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.03767601 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.00094477 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.93304265 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90716383 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.89151800 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.77500991 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.73395870 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73030762 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.65279710 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.62114150 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.54080350 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47744181 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43737195 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.31658430 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29372244 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.29364072 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26901673 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23771133 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22691532 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.19893568 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19596226 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18060119 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16715777 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14087917 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10261614 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09640285 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04518136 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02914617 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.02807910 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91075428 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90272303 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87913228 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83576584 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83227751 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82349355 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82036313 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82008272 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78707278 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.77508879 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70391653 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69412128 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65247651 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64847344 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63737954 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59546024 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59328770 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57646537 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54906661 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.53889445 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49196208 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47145191 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46188850 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44820525 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44524399 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43799763 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41643162 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.37054518 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35051962 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33499297 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32428896 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30328254 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29607651 |
| 77 | Salivary secretion_Homo sapiens_hsa04970 | 0.29083047 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28066107 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27401316 |
| 80 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.27352813 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27209909 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26888673 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26243014 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26183581 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25914749 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24916741 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.24901783 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24231384 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.24035495 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20183420 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.18875354 |
| 92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17537008 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.12692607 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.11289914 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.09882883 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.09449564 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.09147089 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.08813743 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.08379012 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.06289149 |

